Medicinal products for the treatment of Alzheimer's disease and other dementias

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Currently under revision - see below

Reference numberCPMP/EWP/553/1995 Rev. 1
Published24/07/2008
Effective from01/02/2009
KeywordsAlzheimer’s disease, dementia, Lewy body disease, Parkinson’s disease, disease modifying treatment, prevention, symptomatic treatment, vascular dementia
DescriptionThis document provides guidance on the development of medicinal products for the treatment of dementia and its subtypes. It addresses Alzheimer’s disease, vascular dementia, dementia associated with Parkinson’s disease and Lewy body disorder, Huntington’s disease or fronto-temporal dementia.


Document history

Revision 2


 

Draft guideline



Concept paper


Concept paper

Published: 01/02/2016

Deadline for comments: 31/07/2016


Published: 31/10/2013


Published: 26/03/2012

Revision 1 

Current version

Adopted guideline


Draft guideline


Concept paper

In operation: 01/02/2009–present


Published: 19/07/2007


Published: 17/11/2005


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
1 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more